Gasdermin D-dependent platelet pyroptosis exacerbates NET formation and inflammation in severe sepsis
Meiling Su,Chaofei Chen,Shaoying Li,Musheng Li,Zhi Zeng,Yuan Zhang,Luoxing Xia,Xiuzhen Li,Dezhong Zheng,Qiqi Lin,Xuejiao Fan,Ying Wen,Yingying Liu,Feiyan Chen,Wei Luo,Yun Bu,Jinhong Qin,Manli Guo,Miaoyun Qiu,Lei Sun,Renjing Liu,Ping Wang,John Hwa,Wai Ho Tang
DOI: https://doi.org/10.1038/s44161-022-00108-7
Abstract:Platelets have emerged as key inflammatory cells implicated in the pathology of sepsis, but their contributions to rapid clinical deterioration and dysregulated inflammation have not been defined. Here, we show that the incidence of thrombocytopathy and inflammatory cytokine release was significantly increased in patients with severe sepsis. Platelet proteomic analysis revealed significant upregulation of gasdermin D (GSDMD). Using platelet-specific Gsdmd-deficient mice, we demonstrated a requirement for GSDMD in triggering platelet pyroptosis in cecal ligation and puncture (CLP)-induced sepsis. GSDMD-dependent platelet pyroptosis was induced by high levels of S100A8/A9 targeting toll-like receptor 4 (TLR4). Pyroptotic platelet-derived oxidized mitochondrial DNA (ox-mtDNA) potentially promoted neutrophil extracellular trap (NET) formation, which contributed to platelet pyroptosis by releasing S100A8/A9, forming a positive feedback loop that led to the excessive release of inflammatory cytokines. Both pharmacological inhibition using Paquinimod and genetic ablation of the S100A8/A9-TLR4 signaling axis improved survival in mice with CLP-induced sepsis by suppressing platelet pyroptosis.